// App-Quantinova.ai

P-136 : Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor patients (SCAN): Early diagnosis and treatment availability

Researchers

Presenter

  • T. Kolarova

Principal Investigators

  • M. McDonnell

  • D. Van Genechten

  • C. Bouvier

  • C. Rodien-Louw

  • S. Dureja

  • S. Leyden

Medical Centers

  • International Neuroendocrine Cancer Alliance, Boston, MA

  • NET Patient Network, Dublin, Ireland

  • vzw NET & MEN Kanker, Kortrijk, Belgium

  • Neuroendocrine Cancer UK, Leamington Spa, United Kingdom

  • APTED Association de Patients Porteurs de Tumeurs Endocrines Diverses, Lyon, France

  • Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute, Gurgaon, India

  • NeuroEndocrine Cancer Australia, Victoria, Australia

Locations

  • United States

  • Ireland

  • Belgium

  • United Kingdom

  • France

  • India

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroendocrine tumors

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved